Universal hepatitis B immunization: Infant, and infant plus adolescent immunization

Vaccine

Volumn 16, Issue SUPPL., 1998, Pages

  Bonanni, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Adolescents; Coverage; Hepatitis B; Incidence of disease; Infants; Universal immunization programmes

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; YELLOW FEVER VACCINE;

ADOLESCENT; BACTERIAL INFECTION; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; HEALTH CARE POLICY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INFANT; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUBERCULOSIS; VACCINATION; VIRUS HEPATITIS; VIRUS INFECTION; VIRUS TRANSMISSION;

ADOLESCENT; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; PRACTICE GUIDELINES; WORLD HEALTH ORGANIZATION;

EID: 0032429846     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00286-2     Document Type: Conference Paper

References (13)

1. Kane M, Ghendon Y, Lambert PH. Where are we: the WHO programme for control of viral hepatitis. In: Hollinger F.B., Lemon S.M., Margolis H.S., editors. Viral Hepatitis and Liver Disease. Baltimore: Williams and Wilkins, 1991. pp. 706-708.
2. Grosheide P, Van Damme P. Prevention and control of hepatitis B in the community. In: Hallauer J, Kane MA, McCloy E, Meheus A, Roure C, editors. Communicable Diseases Series No. 1. Antwerp: Viral Hepatitis Prevention Board, University of Antwerp, 1996.
3. Roure C. Overview of the epidemiology and disease burden of hepatitis B in the European region. Vaccine 1995;13(Suppl. 1):S18-S21.
4. Redeker AG. Viral hepatitis: clinical aspects. Am. J. Med. Sci. 1975;270:9-16.
5. McMahon BJ, Alward WLM, Hall DB, Heyward WL, Bender TR, Francis DP, Maynard JE. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and the subsequent development of the carrier state. J. Infect. Dis. 1985;151:599-603.
6. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin. Liver Dis. 1991;11:84-92.
7. Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, Mares A, Miller JK, Moyer LA. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. J. Am. Med. Assoc. 1990;263:1218-22.
8. Buyle MH, Torrance GW, Sinclair JC, Horwood SP. Economic evaluation of neonatal intensive car of very-low-birth-weight infants. N. Engl. J. Med. 1983;308:1330-7.
9. Weinstein MC, Stason WB. Cost-effectiveness of interventions to prevent or treat coronary heart disease. Ann. Rev. Public Health 1985;6:41-63.
10. Torrance GW, Zipurky A. Cost-effectiveness of antepartum prevention of Rh immunization. Clin. Perinatol. 1984;11:267-81.
11. Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet 1991;337:747-50.
12. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med. 1997;336:1855-99.
13. Bonanni P. Implementation in Italy of a universal vaccination programme against hepatitis B. Vaccine 1995;13(Suppl. 1):S68-S71.